reports
EQS-News: CureVac veröffentlicht am 24. April 2024 Finanzergebnisse de...
Emittent / Herausgeber: CureVac / Schlagwort(e): Sonstiges CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung 18.04.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung TÜBINGEN, Germany/BOSTON, USA – 18. April 2024 – CureVac N.V. (Nasdaq: CVAC), ein biopharmazeutisches U...
EQS-News: CureVac to Report Fourth Quarter and Full-Year 2023 Financia...
Issuer: CureVac / Key word(s): Miscellaneous CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 18.04.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 TÜBINGEN, Germany/BOSTON, USA – April 18, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“m...
Mawson Infrastructure Group Inc. Announces Monthly Operational Update ...
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024 Total Revenue Doubled with 100% Y/Y Growth from March of last year March Self-Mining Business Revenue up 182% Y/Y March Co-Location Business Revenue up 54% Y/Y March Total Revenue of about $5.44 million MIDLAND, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced today its unaudited business and operational update for March 2024. Rahul Mewawalla, CEO and President, commented, “We are very plea...
SpringWorks Therapeutics to Report First Quarter 2024 Financial Result...
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 2024 to report its first quarter financial results and discuss recent business updates. To join the live webcast and view the corresponding slides, please click . To access the live call by phone, please p...
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dress...
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon oc...
Success for Terranet - tests conducted at AstaZero's test track valida...
Success for Terranet - tests conducted at AstaZero's test track validate BlincVision's potential Terranet AB (publ) has conducted tests in AstaZero's test environment and obtained positive outcomes for the company. The results demonstrate significant potential for the company's Advanced Driver Assistance System, BlincVision. The tests have been conducted at a Euro NCAP-approved test facility, meaning that these results directly contribute to Euro NCAP's ADAS rating methods for 2026. In the fall of 2023, Terranet was granted funding from the innovation agency Vinnova. The funding entailed c...
Framgång för Terranet - tester utförda på AstaZeros testbana validerar...
Framgång för Terranet - tester utförda på AstaZeros testbana validerar BlincVisions potential Terranet AB (publ) har genomfört tester i AstaZeros testmiljö och erhållit för bolaget positiva utfall. Resultaten visar på stor potential för bolagets förarstödssystem BlincVision. Testerna har genomförts på en av Euro NCAP godkänd testanläggning, vilket innebär att dessa resultat direkt bidrar till Euro NCAP’s* ADAS betygsmetoder för 2026. Under hösten 2023 beviljades Terranet bidrag från innovationsmyndigheten Vinnova. Bidraget innebar att tillsammans med AstaZero utveckla nya provmetoder för a...
BlueHalo Awards Mercury Production Agreement to Provide Digital Signal...
BlueHalo Awards Mercury Production Agreement to Provide Digital Signal Processing Hardware for U.S. Space Force Satellite Control System ANDOVER, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), a technology company that delivers mission-critical processing power to the edge, today announced a production agreement with BlueHalo, the company transforming the future of global defense, to support the U.S. Space Force (USSF)’s Satellite Communication Augmentation Resource (SCAR) program. Within the scope of the agreement, Mercury will provide a field-progra...
Good Supply Cannabis Brand Celebrates Earth Day and Unveils Environmen...
Good Supply Cannabis Brand Celebrates Earth Day and Unveils Environmental Impact of “Green You Can Feel Good About” Campaign TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced a sustainability update on its pioneering sustainable packaging initiative within its popular Canadian cannabis brand, Good Supply®. This Earth Day, Good Supply is proud to showcase significant strides in their environmental efforts as they expand the rollout of hemp-based packa...
BlackRock® Canada Announces April Cash Distributions for the iShares® ...
BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs Listing:TSX (Toronto Stock Exchange) Symbol:CBH, CBO, CDZ, CEW, CLF, CLG, CMR, CPD, CUD, CVD, CYH, FIE, XAGG, XAGG.U, XAGH, XBB, XCB, XCBG, XCBU, XCBU.U, XDG, XDG.U, XDGH, XDIV, XDU, XDU.U, XDUH, XDV, XEB, XEI, XFLB, XFN, XFR, XGB, XHB, XHD, XHU, XHY, XIG, XIGS, XLB, XPF, XQB, XRE, XSAB, XSB, XSC, XSE, XSH, XSHG, XSHU, XSHU.U, XSI, XSTB, XSTH, XSTP, XSTP.U, XTLH, XTLT, XTLT.U, XTR, XUT Listing:Cboe Canada (NEO Exchange Inc.) Symbol:XGGB TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- BlackRock Asset Managemen...
Bio-Path Holdings Announces Successful Completion of Higher Dose Secon...
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients BP1002 Offers Unique Opportunity for Venetoclax-Resistant AML Patients Utilizing RNAi to Limit AML Cell’s Ability to Produce Cancer Enabling Bcl-2 Protein HOUSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announ...
Benitec Biopharma Announces Oversubscribed Private Placement Financing...
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announced a $40.0 million private investment in public equity (PIPE) financing from the sale of 5,749,152 shares of its common stock at a price per share of $4.80, and, in lieu of shares...
ECARX Announces Strategic Partnership with FAW Group to Develop Intell...
ECARX Announces Strategic Partnership with FAW Group to Develop Intelligent Cockpits for Its Premium Hongqi Brand SHANGHAI, China, April 18, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced a strategic partnership with China FAW Group Co., Ltd. (“FAW Group”), China’s leading automaker, to develop next-generation intelligent cockpits for the premium Hongqi brand of vehicles. ECARX and FAW will combine their considerable research and development capabilities and technological strengths to build an ...
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinica...
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis —Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), Showing that It is Associated with Disease Severity Across the Fibrotic and Vascular Manifestations of SSc— TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics ...
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Lo...
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today that the U.S. Food & Drug Administration (“FDA”) has accepted the Company’s meeting request for the Revive LC POC Lateral Flow Test Kit (the “Product”) for feedback...
First Advantage to Release First Quarter 2024 Financial Results and Ho...
First Advantage to Release First Quarter 2024 Financial Results and Hold Investor Conference Call on May 9, 2024 ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of employment background screening, identity, and verification solutions, will issue its first quarter 2024 financial results on Thursday, May 9, 2024 prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. Conference Call Details To participate in the conference call, please dial 800-343-4136 (domestic) or 203-518-9843 (int...
Mayfair Gold Announces the Appointment of Vice President Technical Ser...
Mayfair Gold Announces the Appointment of Vice President Technical Services MATHESON, Ontario, April 18, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) is pleased to announce the appointment of Richard Klue to the position of Vice President Technical Services of Mayfair Gold. Mr. Klue has over 40 years of experience in the mining, minerals, and metals industry, and has held numerous senior leadership positions overseeing global engineering studies, projects, and engineering programs. Most recently, Mr. Klue was Vice President Engineerin...
Bacchus Capital Engaged as Strategic & Project Funding Adviser
Bacchus Capital Engaged as Strategic & Project Funding Adviser TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to announce that it has engaged Bacchus Capital Advisers Limited (Bacchus) as its strategic and project funding adviser in relation to the Kharmagtai Copper-Gold Project in the South Gobi region of Mongolia. Highlights Xanadu is executing a Pre-Feasibility Study (PFS) at its Kharmagtai copper-gold project, a 50-50 joint venture with Zijin Mining Group Co Ltd (Zijin). The PFS will be completed in Q3 CY2024...
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on F...
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology Oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis (MS) patients with PIRA as measured by changes in PET scans NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces a platform present...
Mobilicom and Airbus complete successful integration and flight proof-...
Mobilicom and Airbus complete successful integration and flight proof-of-concept on Airbus Mid-Sized Jet-UAV for long-range operations Mobilicom has expanded its offering and total addressable market (TAM) beyond small-sized drones into the mid-sized uncrewed aerial vehicle (UAV) market with its newly released MCU-70 & MCU-300 products Major milestone delivering live HD video and broadband data from high-speed jet UAV over long range operations up to 100 km Shoham, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.